Brazilian Health Regulatory Agency approves Phase 2b/3 study miR-AGE of ABX464 in COVID-19 patients

miR-AGE study has been approved by French and German regulators, and most recently by the British and Italian regulatory authorities

French government announced the selection of six COVID-19 projects to finance with a total of 78m EUR, with Abivax to receive 36m EUR

Final agreements for the 36m EUR funding have been signed with Bpifrance

Patient enrollment in ulcerative colitis Phase 2b trial post COVID-19 getting back on track, with 113 of 232 randomized to date

All resolutions presented during the general meeting were adopted